Table 5.
Baseline characteristics of the patients in the present study.
| Baseline Conditions | Total (n: 122) | Benign (n: 81) | Malignant (n: 41) | p Value |
|---|---|---|---|---|
| Age (years) | 51.4 (SD: 15.7; range:14–91) | 49.8 (SD: 15.7; range: 14–81) | 54.8 (SD: 15.2; range: 14–91) | 0.100 |
| Menopause | 0.018 | |||
| Yes | 62 (50.8%) | 35 (43.2%) | 27 (65.9%) | |
| No | 60 (49.2%) | 46 (56.8%) | 14 (34.1%) | |
| Parity | 0.137 | |||
| Nulliparous | 54 (44.3%) | 32 (39.5%) | 22 (53.7%) | |
| Parous | 68 (55.7%) | 49 (60.5%) | 19 (46.3%) | |
| BMI (kg/m) | 26.6 (SD: 5.4; range 18.6–42.0) | 28.0 (SD: 5.5; range: 18.8–42.0) | 26.6 (SD: 6.0; range: 18.6–41.0) | 0.409 |
| Symptoms | 0.362 | |||
| Asymptomatic | 48 (39.3%) | 36 (44.4%) | 12 (29.3%) | |
| Digestive | 41 (33.6%) | 25 (30.9%) | 16 (39.0%) | |
| Bleeding | 10 (8.2%) | 7 (8.6%) | 3 (7.3%) | |
| Other | 23 (18.9%) | 13 (16.0%) | 10 (24.4%) |
SD: standard deviation.